Whalegun
Insider trades

Kush Parmar, 10% Owner of Skye Bioscience SKYE, has filed 5 purchases and 32 sales on the open market. Over the past 12 months that comes to a net sale of $2M. The latest trade was on 09/23.

Kush Parmar

10% Owner
Company
Skye Bioscience SKYE
First filing
23/01/05
Trades
58 trades
Buys / sales
5 / 32
12-month net buying
−$2M
Last trade
09/23

Trading activity

Transactions

Trade type
SKYE
Open-market sale09/22–09/2309/24148,079 sh4 trades$1.62avg.$239,555.19−100.0%
Entrada TherapeuticsTRDA
Open-market sale25/11/1425/11/18200,000 sh$8.80$1,760,000−6.3%
Camp4 TherapeuticsCAMP
Open-market buy25/09/1125/09/152,941,176 sh$1.53$4,499,999.28No record
SKYE
Open-market sale25/08/21–25/08/2225/08/22231,405 sh4 trades$3.46avg.$800,548.5−80.1%
TRDA
Open-market sale25/07/0925/07/1127,000 sh2 trades$7.50avg.$202,500−2.4%
TRDA
Open-market sale25/06/27–25/07/0125/07/01125,000 sh6 trades$6.93avg.$866,500−10.2%
Camp4 TherapeuticsCAMP
Open-market buy24/10/1524/10/15909,090 sh$11.00$9,999,990+53.0%
SKYE
Open-market sale24/09/11–24/09/1324/09/13266,337 sh6 trades$6.57avg.$1,750,352.22−80.1%
Artiva BiotherapeuticsARTV
Open-market buy24/07/2224/07/24833,333 sh$12.00$9,999,996+239.0%
Skye BioscienceSKYE
Open-market buy24/03/1324/03/15450,000 sh$10.00$4,500,000+5.7%
ELVN
Open-market sale24/02/1424/02/16825,000 sh2 trades$14.90avg.$12,292,500−56.5%
Skye BioscienceSKYE
Open-market buy24/01/3124/02/025,206,074 sh$2.31$12,026,030.94+190.2%
ELVN
Open-market sale24/01/3124/02/02500,000 sh2 trades$15.00avg.$7,500,000−39.3%
ELVN
Open-market sale23/09/2623/09/28197,500 sh2 trades$15.00avg.$2,962,500−18.8%
ELVN
Open-market sale23/08/2423/08/28440,000 sh2 trades$16.00avg.$7,040,000−33.1%
RallybioRLYB
Open-market sale23/03/0723/03/09100,000 sh$8.20$820,000−4.0%